Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Efficacy And Safety Study Of SU011248 In Patients With Non-Small Cell Lung Cancer And Brain Metastases

NCT00372775 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00372775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00372775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Efficacy And Safety Study Of SU011248 In Patients With Non-Small Cell Lung Cancer And Brain Metastases
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2007
Completion date
December 31, 2009
Enrollment
66 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer